These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 3130176

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.
    Waxman JH, Wass JA, Hendry WF, Whitfield HN, Besser GM, Malpas JS, Oliver RT.
    Br Med J (Clin Res Ed); 1983 Apr 23; 286(6374):1309-12. PubMed ID: 6404441
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Lack of effect of therapy with LHRH analogs, alone or associated with flutamide, on prolactin levels in advanced prostatic carcinoma].
    Banchini A, Zavaroni D, Tarditi E, Cortellini P, Ziveri M, Polotti R, Stefani F, Valenti G.
    Minerva Endocrinol; 1989 Apr 23; 14(3):165-8. PubMed ID: 2533662
    [Abstract] [Full Text] [Related]

  • 10. Clinical importance of prostatic measurements in follow-up of GnRH analogue-treated prostatic carcinoma patients.
    Matzkin H, Greenstein A, Braf Z.
    Urology; 1990 Sep 23; 36(3):214-8. PubMed ID: 2118285
    [Abstract] [Full Text] [Related]

  • 11. Three-monthly GnRH agonist (buserelin) for prostatic cancer.
    Waxman J, Sandow J, Abel P, Barton C, Keane P, Williams G.
    Br J Urol; 1990 Jan 23; 65(1):43-5. PubMed ID: 2107012
    [Abstract] [Full Text] [Related]

  • 12. Treatment of prostatic cancer with a gonadotropin-releasing hormone agonist analog: acute and long term effects on endocrine functions of testis tissue.
    Huhtaniemi I, Nikula H, Rannikko S.
    J Clin Endocrinol Metab; 1985 Oct 23; 61(4):698-704. PubMed ID: 2993345
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transabdominal ultrasonography in the evaluation of patients with advanced prostatic carcinoma: effects of castration and of chronic administration of a gonadotropin releasing hormone agonistic analogue.
    Tolis G, Koutsilieris M, Fazekas AT, Patton R.
    Prostate; 1983 Oct 23; 4(6):595-600. PubMed ID: 6415631
    [Abstract] [Full Text] [Related]

  • 19. Response of circulating gonadotropin levels to GnRH agonist treatment in prostatic cancer.
    Huhtaniemi I, Venho P, Jacobi G, Rannikko S.
    J Androl; 1991 Oct 23; 12(1):46-53. PubMed ID: 1901309
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.